Objectives: To describe and assess the risk of bias of the primary input studies that
underpinned the Global Burden of Disease Study (GBD) 2019 modelled prevalence …

Background: Global policy to guide action on musculoskeletal (MSK) health is in a nascent
phase. Lagging behind other non-communicable diseases (NCDs) there is currently little …

Musculoskeletal (MSK) health impairments contribute substantially to the pain and disability
burden in low-and middle-income countries (LMICs), yet health systems strengthening …

Introduction Despite the profound burden of disease, a strategic global response to optimise
musculoskeletal (MSK) health and guide national-level health systems strengthening …

Background Exacerbated by an aging population, musculoskeletal diseases are a chronic
and growing problem in the United States that impose significant health and economic …

Actions towards the health-related Sustainable Development Goal 3.4 typically focus on non-
communicable diseases (NCDs) associated with premature mortality, with less emphasis on …

BACKGROUND: Despite the rising burden of musculoskeletal (MSK) problems (MSK
conditions, MSK pain, and MSK injury and trauma) in most countries, actions to improve …

Abstract On 12 September 2019, the global Patient Reported Outcome for Multiple Sclerosis
(PROMS) Initiative was launched at the 35th Congress of the European Committee for …

DISCUSSION What are SDH? There is growing evidence that health outcomes (eg,
mortality/life expectancy, quality of life, health status, functional limitations) are explained …

Osteoarthritis (OA) is a leading cause of long-term disability worldwide 1 and places a
significant burden on individuals, health care providers, and the wider economy. 2 …